Kaijun Cui

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

CAR T‐cell immunotherapy: The path from the by‐road to the freeway?

CAR-T cell therapy: current limitations and potential strategies

Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response

A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies

Cellular Immunotherapy for Carcinoma Using Genetically Modified EGFR-Specific T Lymphocytes